Cargando…

Renal function after intravitreal administration of vascular endothelial growth factor inhibitors in patients with diabetes and chronic kidney disease

The present study aimed to determine whether intravitreal administration of vascular endothelial growth factor inhibitors is associated with deterioration of renal function, as seen with systemic administration, in patients with diabetes and chronic kidney disease. Estimated glomerular filtration ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kameda, Yusuke, Babazono, Tetsuya, Uchigata, Yasuko, Kitano, Shigehiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031523/ https://www.ncbi.nlm.nih.gov/pubmed/29108104 http://dx.doi.org/10.1111/jdi.12771

Ejemplares similares

Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
por: Kameda, Yusuke, et al.
Publicado: (2021)

Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis
por: Kameda, Yusuke, et al.
Publicado: (2019)

Giant retinal pigment epithelial tear associated with fluid overload due to end-stage diabetic kidney disease
por: Kameda, Yusuke, et al.
Publicado: (2016)

Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus
por: Toya, Kiwako, et al.
Publicado: (2013)

Comparison of spironolactone and trichlormethiazide as add‐on therapy to renin–angiotensin blockade for reduction of albuminuria in diabetic patients
por: Hase, Michiyo, et al.
Publicado: (2013)

Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
por: Otani, Toshika, et al.
Publicado: (2019)

Obesity as an effect modifier of the association between leptin and diabetic kidney disease
por: Hanai, Ko, et al.
Publicado: (2013)

Relationship between diabetic nephropathy and depression: a cross-sectional analysis using the Diabetes Study from the Center of Tokyo Women's Medical University (DIACET)
por: Takasaki, Keiko, et al.
Publicado: (2016)

Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti‐glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme‐linked immunosorbent assay
por: Takagi, Satoshi, et al.
Publicado: (2019)

Prediction of Retinopathy at 20 Years After Onset in Younger-Onset Type 1 Diabetes Using Mean Metabolic Memory-Free HbA(1c) Values: The importance of using HbA(1c) data of total, not partial, diabetes duration
por: Hirose, Akira, et al.
Publicado: (2013)

Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy
por: Ou, Shih-Hsiang, et al.
Publicado: (2022)

Association of Serum Leptin Levels With Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes
por: Hanai, Ko, et al.
Publicado: (2011)

Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach
por: Petri, Anne-Sofie, et al.
Publicado: (2020)

Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease
por: Takagi, M., et al.
Publicado: (2015)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
por: Thinggaard, Benjamin Sommer, et al.
Publicado: (2023)

Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use
por: Hanna, Ramy M., et al.
Publicado: (2020)

Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018)

Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease
por: O’Neill, Rachael Ann, et al.
Publicado: (2019)

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
por: Xiao, Xiang, et al.
Publicado: (2022)

Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study
por: Campbell, Robert J, et al.
Publicado: (2012)

Pituitary Apoplexy After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitor: A Novel Complication
por: Kasl, Rebecca A., et al.
Publicado: (2015)

Nephrotic Syndrome with Focal Segmental Glomerulosclerosis Induced by Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitor
por: Kakeshita, Kota, et al.
Publicado: (2020)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
por: Ben Ghezala, Inès, et al.
Publicado: (2022)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
por: Hang, Abraham, et al.
Publicado: (2023)

Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Factors associated with hypoglycemia unawareness and severe hypoglycemia in type 1 diabetes mellitus patients
por: Takagi, Satoshi, et al.
Publicado: (2022)

Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device
por: Fukuo, Motonobu, et al.
Publicado: (2016)

Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema
por: Hertzberg, Silvia NW, et al.
Publicado: (2022)

Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
por: Zhou, Yandan, et al.
Publicado: (2016)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Presumed Pyogenic Granuloma Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy
por: Jung, Jesse J, et al.
Publicado: (2011)

Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014)

Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit
por: Fiebai, Bassey, et al.
Publicado: (2017)

Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
por: Zina, Sourour, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
por: Rai, Bhim Bahadur, et al.
Publicado: (2023)

Effect of repeated intravitreal anti-vascular endothelial growth factor drugs on corneal nerves
por: Qi, Yuanyuan, et al.
Publicado: (2023)

Anterior Chamber Paracentesis Offers a Less Painful Experience During Intravitreal Anti-vascular Endothelial Growth Factor Administration: An Intraindividual Study
por: Karakahya, Refika Hande
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9fbvvqb2gg2iqt99172reiv56